NASDAQ
Aprea Therapeutics, Inc. (APRE) has a free cash flow growth of 10.11% as of Friday, May 29, 2026. This represents a 233.21% increase compared to its 12-month average of 3.04%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.